Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00477256 · ClinicalTrials.gov registry record
School Reintegration Outcomes in Pediatric Cancer Patients
A clinical trial of Pediatric Cancers, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 91
- Enrollment target
- 1
- Study location
NCT00477256: Completed study of Pediatric Cancers, sponsored by M.D. Anderson Cancer Center.
NCT00477256 is a study of Pediatric Cancers that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 91 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00477256, a study of Pediatric Cancers, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 91 participants
- Enrollment target
- 1
- Study location
Study Summary
Primary Objectives: 1. To examine illness-related factors (i.e., severity of illness, quality of life rating) as predictors or correlates of child adjustment to pediatric cancer. 2. To examine illness-related factors (i.e., severity of illness, quality of life rating) as predictors of school reintegration (i.e., school attendance) in children with pediatric cancer. 3. To examine a within-parent factor (i.e., parental stress) as a predictor or correlate of child adjustment to pediatric cancer. 4. To examine a within-parent factor (i.e., parental stress) as a predictor or correlate of school reintegration (i.e., school attendance). Secondary Objectives: 1. To examine a second within-parent factor (i.e., parental perception of child vulnerability) as a predictor or correlate of child adjustment to pediatric cancer. 2. To examine a second within-parent factor (i.e., parental perception of child vulnerability) as a predictor or correlate of school reintegration (i.e., school attendance) in children with pediatric cancer. 3. To develop a statistical model by which relative contributions of each predictor variable (i.e., severity of illness, quality of life, parental stress, parental perception of child vulnerability), as well as their interrelatedness, can be understood in relation to child adjustment. Exploration of each variable's contribution will affect the schematic organization of the model. 4. To examine demographic variables as covariates in the primary analyses. The variables include: child's age, gender, grade, ethnicity, diagnosis, time since diagnosis, type and duration of treatment, and time since school reintegration.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaires
Study Locations (1)
Texas
- UT MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2007-05 |
| Est. Completion | 2010-10 |
What the finished NCT00477256 record still lists
NCT00477256 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 91 participants, a relatively small participant target.
The record links to 1 condition, with Pediatric Cancers appearing as the primary indexed condition, and to 1 intervention - of which Questionnaires is the first listed.
NCT00477256 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00477256 about?
NCT00477256 is a clinical study titled "School Reintegration Outcomes in Pediatric Cancer Patients". Primary Objectives: 1. To examine illness-related factors (i.e., severity of illness, quality of life rating) as predictors or correlates of child adjustment to pediatric cancer. 2. To examine illness-related factors (i.e., severity of illness, quality of life rating) as predictors of school reinte...
What is the current status of trial NCT00477256?
This trial is currently completed. The enrollment target is 91 participants. The study started on 2007-05. Estimated completion is 2010-10.
What conditions does trial NCT00477256 study?
This clinical trial studies the following conditions: Pediatric Cancers.
What interventions are being tested in trial NCT00477256?
The interventions under investigation include: Questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT00477256?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00477256 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia